Suchergebnisse - (Person:"Nie, Jianhui")

PubPharm (40)

1

Rational prediction of immunogenicity clustering through cross-reactivity analysis of thirteen SARS-CoV-2 variants

enthalten in: Journal of medical virology | 2024

von Liang, Z. | Tong, J. | Sun, Z. | +11

2

Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1

enthalten in: Emerging microbes & infections | 2023

von Liu, S. | Liang, Z. | Nie, J. | +6

3

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector

enthalten in: Emerging microbes & infections | 2023

von Liang, Z. | Wu, X. | Wu, J. | +11

4

Pseudotyped Viruses

enthalten in: Advances in experimental medicine and biology | 2023

von Wang, Y. | Zhou, Z. | Wu, X. | +6

5

Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice

enthalten in: Frontiers in immunology | 2023

von Li, X. | Liu, J. | Li, W. | +19

6

Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination

enthalten in: Emerging microbes & infections | 2022

von Wang, M. | Zhang, L. | Li, Q. | +10

7

Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice

enthalten in: Emerging microbes & infections | 2022

von Li, X. | Wang, L. | Liu, J. | +21

8

Analysis of SARS-CoV-2 variants B.1.617 : host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity

enthalten in: Emerging microbes & infections | 2022

von Zhang, L. | Li, Q. | Wu, J. | +19

9

Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift

enthalten in: Journal of medical virology | 2022

von Li, T. | Cui, Z. | Jia, Y. | +17

10

The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain

enthalten in: Signal transduction and targeted therapy | 2022

von Wu, J. | Nie, J. | Zhang, L. | +16